These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27634322)

  • 1. Bringing the Hepatitis C Virus to Life.
    Cell; 2016 Sep; 167(1):39-42. PubMed ID: 27634322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioneering a Global Cure for Chronic Hepatitis C Virus Infection.
    Vilarinho S; Lifton RP
    Cell; 2016 Sep; 167(1):12-15. PubMed ID: 27634325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2016 Lasker-DeBakey Clinical Medical Research Award: Innovative hepatitis C virus (HCV) replicons leading to drug development for hepatitis C cure.
    Zhao Q; Xia N
    Sci China Life Sci; 2016 Nov; 59(11):1198-1201. PubMed ID: 27785725
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C Virus-From Discovery to Cure: The 2016 Lasker-DeBakey Clinical Medical Research Award.
    Bartenschlager RF; Rice CM; Sofia MJ
    JAMA; 2016 Sep; 316(12):1254-5. PubMed ID: 27623041
    [No Abstract]   [Full Text] [Related]  

  • 5. Ralf Bartenschlager, Charles Rice, and Michael Sofia are honored with the 2016 Lasker~DeBakey Clinical Medical Research Award.
    Williams CL
    J Clin Invest; 2016 Oct; 126(10):3639-3644. PubMed ID: 27620536
    [No Abstract]   [Full Text] [Related]  

  • 6. Profile of Charles M. Rice, Ralf F. W. Bartenschlager, and Michael J. Sofia, 2016 Lasker-DeBakey Clinical Medical Research Awardees.
    Palese P
    Proc Natl Acad Sci U S A; 2016 Dec; 113(49):13934-13937. PubMed ID: 27864510
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C Virus: From Obscurity to the Lasker.
    Liang TJ
    Gastroenterology; 2016 Dec; 151(6):1052-1053. PubMed ID: 27765691
    [No Abstract]   [Full Text] [Related]  

  • 8. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
    Suzuki T
    Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timeline: Targeted Treatment of Hepatitis C Virus.
    Teitzel G
    Cell; 2016 Sep; 167(1):288. PubMed ID: 27662096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development.
    Lohmann V
    Med Microbiol Immunol; 2019 Feb; 208(1):3-24. PubMed ID: 30298360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.
    McHutchison JG; Bartenschlager R; Patel K; Pawlotsky JM
    J Hepatol; 2006 Feb; 44(2):411-21. PubMed ID: 16364491
    [No Abstract]   [Full Text] [Related]  

  • 12. Existing and future therapeutic options for hepatitis C virus infection.
    Bretner M
    Acta Biochim Pol; 2005; 52(1):57-70. PubMed ID: 15827606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV versus HIV drug discovery: Déjà vu all over again?
    Watkins WJ; Desai MC
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2281-7. PubMed ID: 23489621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of hepatitis C infection.
    Drazan KE
    Liver Transpl; 2000 Jul; 6(4):396-406. PubMed ID: 10915159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus: molecular biology & current therapeutic options.
    Sharma SD
    Indian J Med Res; 2010 Jan; 131():17-34. PubMed ID: 20167971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus.
    Horscroft N; Lai VC; Cheney W; Yao N; Wu JZ; Hong Z; Zhong W
    Antivir Chem Chemother; 2005; 16(1):1-12. PubMed ID: 15739617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches to the development of novel inhibitors of hepatitis C virus replication.
    Clarke BE
    J Viral Hepat; 1995; 2(1):1-8. PubMed ID: 7493290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV research and anti-HCV drug discovery: toward the next generation.
    Wakita T
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The way forward in HCV treatment--finding the right path.
    Manns MP; Foster GR; Rockstroh JK; Zeuzem S; Zoulim F; Houghton M
    Nat Rev Drug Discov; 2007 Dec; 6(12):991-1000. PubMed ID: 18049473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.